MedPath

HAAL: HeAlthy Ageing Eco-system for peopLe With Dementia

Not Applicable
Recruiting
Conditions
Devices
Artificial Intelligence
Dementia
Caregiver Burden
Older People
Interventions
Device: HAAL platform
Registration Number
NCT06307197
Lead Sponsor
Istituto Nazionale di Ricovero e Cura per Anziani
Brief Summary

HAAL project aims to test several technological devices in order to improve the quality of life of older people with dementia and their informal and formal caregiver.

Detailed Description

The HAAL study is a feasibility study. The general objectives of the HAAL project is to be assessed the stress relief at work for formal and informal caregivers, the improvement in the perceived quality of life for informal caregivers and person with dementia, the reduction in case load for the formal caregivers and the increased cost-effectiveness of the HAAL solution in comparison to the available services. The experimentation will be carried out in 3 sites: Italy, The Netherlands and Taiwan. The study consists in a alpha phase (5 older adults with dementia, 5 formal caregivers and 5 formal caregivers) and in a beta phase (10 older adults with dementia, 10 formal caregivers and 10 formal caregivers).

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
10
Inclusion Criteria
  • being the caregiver of a person with cognitive impairment or dementia;
  • availability of time to participate;
  • visit the assisted person at least two times at week or live with him/her.
Exclusion Criteria
  • Lack of written informed consent

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
older adultsHAAL platform-
Primary Outcome Measures
NameTimeMethod
Care load of caregiversbaseline, 1, 2, and 3 months later

The burden of the caregiver will be assessed through the ZARIT Burden Interview (ZBI). The ZBI is a caregiver self-report measure, containing 22 items. Each item on the interview is a statement which the caregiver is asked to endorse using a 5-point scale. Response options range from 0 (Never) to 4 (Nearly Always).Total score range: 0 to 88. score range 0-21: no to mild burden; score range 21-40: mild to moderate burden; score range 41-60: moderate to severe burden score ≥ 61: severe burden.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

IRCCS INRCA Hospital

🇮🇹

Ancona, Italy

© Copyright 2025. All Rights Reserved by MedPath